Traditional Chinese medicine composition for preventing and treating pulmonary embolism

Abstract

The invention relates to a traditional Chinese medicine composition for preventing and treating pulmonary embolism. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 15-35 parts of angelica sinensis, 10-30 parts of peach seeds, 10-20 parts of zanthoxylum dissitum hemsl, 10-20 parts of camellia, 15-30 parts of vervain, 10-20 parts of long-leaf coluria longifolia, 5-20 parts of veronica undulate, 5-15 parts of radix rehmanniae preparata, 10-20 parts of folium cycas, 5-15 parts of sinapis alba, 5-15 parts of rhizoma atractylodis macrocephalae, 5-15 parts of pinellia ternate, 10-30 parts of viola arcuata, 10-20 parts of panax bipinnatifidus, 10-20 parts of radix calendulae officinalis, 5-15 parts of ephedra sinica, 5-10 parts of radix pseudostellariae, 5-15 parts of spina date seeds, 10-20 parts of astragalus membranaceus, 10-20 parts of cynanchum glaucescens, 5-15 parts of loofah sponge and 5-15 parts of hematoxylon. The traditional Chinese medicine composition has the efficacies of activating blood circulation, eliminating stasis, promoting qi circulation to relieve pain, benefiting qi and nourishing blood, is used for preventing and treating pulmonary embolism, and is free of a toxic or side effect and significant in effect.

Description

technical field [0001] The present invention relates to a pharmaceutical composition, in particular to a traditional Chinese medicine composition for preventing and treating pulmonary embolism. Background technique [0002] Pulmonary embolism (PE) is a general term for a group of diseases or clinical syndromes in which various emboli obstruct the pulmonary artery system as the cause, including pulmonary thromboembolism, fat embolism, amniotic fluid embolism, air embolism, etc. The symptoms can range from asymptomatic to sudden death. Common symptoms are dyspnea and chest pain. The causes of pulmonary embolism are mainly related to trauma surgery, thrombophlebitis, varicose veins, cardiopulmonary diseases, malignant tumors, pregnancy, and the use of hormonal contraceptives. Among them, trauma surgery and pregnancy are the main iatrogenic causes of pulmonary embolism, and postoperative or postpartum pulmonary embolism has high morbidity and mortality. [0003] The current met...

AI Technical Summary

Problems solved by technology

However, whether it is the use of anticoagulant drugs or thrombolytic drugs, it may increase the risk of intraoperative and postoperative bleeding and delay wound healing, so these two methods are not conducive to the prevention of postoperative pulmonary embolism

Surgical treatment of pulmonary embolism is surgical removal of pulmonary artery thrombus or catheter fragmentation of pulmonary embolism. The surgical method has high technical requirements for doctors, and has the disadvantages of high surgical risk, high cost, and high mortality.